California State Teachers Retirement System (CalSTRS)’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,991
Closed -$172K 3093
2021
Q1
$172K Buy
2,991
+109
+4% +$8.23K ﹤0.01% 2948
2020
Q4
$196K Hold
2,882
﹤0.01% 2834
2020
Q3
$731K Buy
2,882
+201
+7% +$41.2K ﹤0.01% 2056
2020
Q2
$451K Buy
+2,681
New +$289K ﹤0.01% 2301

Other funds holding BCLI

California State Teachers Retirement System (CalSTRS)'s BCLI Position: Q2 2021 in Review

California State Teachers Retirement System (CalSTRS) sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q2 2021, closing a stake of 2,991 shares — an estimated $172K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in BCLI in Q2 2020 and held it in 4 quarters. The position peaked at $731K in Q3 2020. 57 funds tracked by Wall St. Rank hold BCLI as of Q2 2021.

  • California State Teachers Retirement System (CalSTRS) reported no remaining BRAINSTORM CELL THERAPUTC position as of Q2 2021 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 2,991 BRAINSTORM CELL THERAPUTC shares in Q2 2021, an estimated $172K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in BRAINSTORM CELL THERAPUTC in Q2 2020 and held it in 4 quarters.
  • California State Teachers Retirement System (CalSTRS)'s BRAINSTORM CELL THERAPUTC position peaked at $731K in Q3 2020.
  • 57 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q2 2021.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2021, filed 16 Aug 2021.